MD-Gastroview® (solution of 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium Solution) is an iodinated oral contrast agent with lemon-vanilla-flavor. MD-Gastroview® is water-soluble and suitable for oral or rectal administration.
MD-Gastroview® is indicated for radiographic and CT examination of the esophagus, stomach, proximal small intestine and colon, when a barium sulfate suspension is not feasible or contraindicated.
A usual adult dose for abdominal CT is 240 mL of a solution prepared by diluting 25 mL (9.17 g iodine) to one liter with tap water. Less dilute solutions [up to 77 mL (28.26 g iodine) diluted to one liter with tap water] may be used when indicated. The dose is administered orally about 15 to 30 minutes prior to imaging in order to permit the contrast medium to reach the pelvic loops.

Mallinckrodt, a Tyco Healthcare company makes and distributes products for respiratory care; bulk and dosage pharmaceuticals, primarily for pain relief and addiction therapy; and imaging agents for magnetic resonance, ultrasound, x-ray, and nuclear medicine applications. With worldwide manufacturing and distribution facilities, as well as worldwide sales offices, Mallinckrodt sells its products worldwide.

In June 2007 Tyco International Ltd. completed the separation of its healthcare business, which is named Covidien. Mallinckrodt, Inc. is now part of Covidien Ltd.